Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older-Reference-Cited by-同舟云学术

Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older

Published:2011-08-24 Issue:1 Volume:53 Page:43-49
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Meguro Akiko,Ozaki Katsutoshi,Sato Kazuya,Oh Iekuni,Fujiwara Shinichiro,Hosonuma Rie,Sasazaki Miyuki,Kikuchi Yuji,Hirata Yuji,Yamamoto Chihiro,Uesawa Mitsuyo,Kobayashi Hiroyuki,Matsu Haruko,Okabe Hiroshi,Uehara Eisuke,Nishikawa Akinori,Tatara Raine,Hatano Kaoru,Yamamoto Chizuru,Matsuyama Tomohiro,Toshima Masaki,Ueda Masuzu,Ohmine Ken,Suzuki Takahiro,Mori Masaki,Nagai Tadashi,Muroi Kazuo,Ozawa Keiya

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.600486

Reference18 articles.

1. Aggressive Lymphomas

2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

3. Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

4. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma

5. Stromal Gene Signatures in Large-B-Cell Lymphomas

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World Evidence;Cancers;2024-04-11

2. Advances in diagnosis, treatment and prognostic factors of gastrointestinal DLBCL;Leukemia Research;2023-12

3. Looking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities;Seminars in Hematology;2023-11

4. An evaluation based on relative treatment intensity in older patients treated with reduced-dose R-THP-COP therapy for diffuse large B-cell lymphoma: A multicenter retrospective cohort study;Journal of Geriatric Oncology;2023-01

5. A Multicenter Study of 239 Patients Aged Over 70 Years With Diffuse Large B-Cell Lymphoma in China;Frontiers in Pharmacology;2022-07-18